Home › Funds › Eversept Partners, LP › NTRA
Eversept Partners, LP position in NTRA
NATERA INC · Health Care
Eversept Partners, LP reported holding 128,126 shares of NTRA (NATERA INC) in its Q3 2026 13F filing — a position valued at US$53.0M, representing 2.85% of its reported portfolio and ranking #8 among its reported holdings. Eversept Partners, LP has disclosed NTRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Eversept Partners, LP's NTRA position evolved
Eversept Partners, LP first disclosed a stake in NTRA in Q3 2023 at 2,492,636 shares (US$110.3M). The position peaked in Q1 2024 at 1,778,051 shares, worth US$162.6M. Across 13 filings, Eversept Partners, LP increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 128,126 shares valued at US$53.0M — a reduction of -47,681 shares quarter over quarter.. Notable position changes include a 35% trim in Q3 2025 (shares rose 42% over the following quarter), a 36% trim in Q4 2025 (shares fell 13% over the following quarter), a 54% trim in Q2 2026 (shares rose 102% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 2.49M | $110.30M | New |
| Q4 2023 | 2.25M | $141.04M | Reduce |
| Q1 2024 | 1.78M | $162.62M | Reduce |
| Q2 2024 | 1.17M | $127.08M | Reduce |
| Q3 2024 | 870.19K | $110.47M | Reduce |
| Q4 2024 | 876.77K | $138.79M | Add |
| Q1 2025 | 893.72K | $126.38M | Add |
| Q2 2025 | 796.38K | $134.54M | Reduce |
| Q3 2025 | 519.64K | $83.65M | Reduce |
| Q4 2025 | 334.49K | $76.63M | Reduce |
| Q1 2026 | 384.71K | $76.94M | Add |
| Q2 2026 | 175.81K | $47.72M | Reduce |
| Q3 2026 | 128.13K | $52.96M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NTRA and 13F data
NTRA (NATERA INC) is a Health Care company. 55 other funds we track also report a position in NTRA — the largest reported positions include Fidelity Management & Research (FMR) (US$5.65B), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$1.07B), COATUE MANAGEMENT LLC (US$1.00B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NTRA
- Fidelity Management & Research (FMR) 13.68M sh · $5.65B · Q3 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 2.60M sh · $1.07B · Q3 2026
- COATUE MANAGEMENT LLC 2.43M sh · $1.00B · Q3 2026
- Duquesne Family Office LLC 3.19M sh · $864.92M · Q2 2026
- Castle Hook Partners LP 2.60M sh · $704.76M · Q2 2026
- Coatue Management 2.51M sh · $680.01M · Q2 2026
- Sofinnova Investments, Inc. 1.55M sh · $640.75M · Q3 2026
- Farallon Capital Management 2.22M sh · $602.18M · Q2 2026
- FEDERATED HERMES, INC. 1.40M sh · $580.62M · Q3 2026
- FRED ALGER MANAGEMENT, LLC 1.78M sh · $482.64M · Q2 2026
- Maverick Capital 1.36M sh · $368.27M · Q2 2026
- MAVERICK CAPITAL LTD 1.36M sh · $368.27M · Q2 2026
More on Eversept Partners, LP
FAQ
How long has Eversept Partners, LP held NTRA?
Eversept Partners, LP has disclosed NTRA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Eversept Partners, LP's current position in NTRA?
As of Q3 2026, Eversept Partners, LP holds 128.13K shares of NTRA (NATERA INC), valued at $52.96M, representing 2.85% of its reported portfolio and ranking #8.
Has Eversept Partners, LP been buying or selling NTRA?
In the latest 13F filing (Q3 2026), Eversept Partners, LP reduced its position in NTRA. The position peaked in Q1 2024 at 1.78M shares.
Which other funds hold NTRA?
Other major institutional holders of NTRA include Fidelity Management & Research (FMR), FARALLON CAPITAL MANAGEMENT, L.L.C., COATUE MANAGEMENT LLC, among 55 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.